PMDA drug package insert
アイオピジンUD点眼液1%
PMDA Prescription drug · クリニジェン株式会社 · package insert Nov 28, 2025
Key facts
| Brand names | アイオピジンUD点眼液1% |
|---|---|
| Nonproprietary names | アプラクロニジン塩酸塩 |
| Companies | 製造販売元／クリニジェン株式会社 |
| Product type | Prescription drug |
| Therapeutic category | レーザー術後眼圧上昇防止剤 |
| Therapeutic category codes | 871319 |
| YJ codes | 1319737Q1038 |
| Approval numbers | 21900AMX00766000 |
| Package insert edition | 第2版 |
| Package insert date | Nov 28, 2025 |
| PMDA document key | 850372_1319737Q1038_3 |
| PMDA company code | 850372 |
At a glance
- 1–9 Package insert revisions
- 1–9 Related PMDA documents
- None Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: